Standard BioTools Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for LAB, updated each market day.
LAB AI Sentiment
AI predicts Standard BioTools Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Standard BioTools Inc. Common Stock
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
Sector
Exchange
Market Cap
$355,394,149
Cap Tier
Employees
389
Headquarters
BOSTON, MA
Listed Since
Feb. 10, 2011
Website
LAB Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
LAB Volatility
Standard BioTools Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
